The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Covalently Combining Carbon Nanotubes with Anticancer Agent: Preparation and Antitumor Activity
Abstract
A multiwalled carbon nanotube (MWNT)-based drug delivery system was developed by covalently combining carbon nanotubes with the antitumor agent 10-hydroxycamptothecin (HCPT) using hydrophilic diaminotriethylene glycol as the spacer between nanotube and drug moieties. The surface functionalizations of the nanotube were carried out by enrichment of carboxylic groups with optimized oxidization treatment, followed by covalently linking hydrophilic diaminotriethylene glycol via amidation reaction, and then HCPT was chemically attached to carbon nanotubes through a cleavable ester linkage. It is demonstrated that the obtained MWNT-HCPT conjugates are superior in antitumor activity both in vitro and in vivo to clinical HCPT formulation. In vivo single photon emission computed tomography (SPECT) imaging and ex vivo gamma scintillation counting analyses reveal that MWNT-HCPT conjugates have relatively long blood circulation and high drug accumulation in the tumor site. These properties together with the enhanced cell uptake and multivalent presentation of HCPT on a single nanotube benefit substantially the antitumor effects and would boost significantly the applications of carbon nanotubes in the biomedicine field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oops they did it again! Carbon nanotubes hoax scientists in viability assays
Wörle-Knirsch, J. M., Pulskamp, K., & Krug, H. F. (2006) · Nano Letters · doi:10.1021/nl060177c · Cited by 994
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Carbon materials for drug delivery & cancer therapy
Liu, Z., Robinson, J. T., Tabakman, S. M., Yang, K., & Dai, H. (2011) · Materials Today · doi:10.1016/s1369-7021(11)70161-4 · Cited by 600
Carbon nanotubes for delivery of small molecule drugs
Wong, B. S., Yoong, S. L., Jagusiak, A., Panczyk, T., Ho, H. K., Ang, W. H., & Pastorin, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.005 · Cited by 585
The application of carbon nanotubes in target drug delivery systems for cancer therapies
Zhang, W., Zhang, Z., & Zhang, Y. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-555 · Cited by 511
Liu, X., Tao, H., Yang, K., Zhang, S., Lee, S.-T., & Liu, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.096 · Cited by 417
Carbon nanotubes: a novel material for multifaceted applications in human healthcare
Kumar, S., Rani, R., Dilbaghi, N., Tankeshwar, K., & Kim, K.-H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00517a · Cited by 397
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Seifalian, A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16923 · Cited by 366
Overview of Carbon Nanotubes for Biomedical Applications
Simon, J., Flahaut, E., & Golzio, M. (2019) · Materials · doi:10.3390/ma12040624 · Cited by 366
Delivery of drugs and biomolecules using carbon nanotubes
Vashist, S. K., Zheng, D., Pastorin, G., Al-Rubeaan, K., Luong, J. H. T., & Sheu, F.-S. (2011) · Carbon · doi:10.1016/j.carbon.2011.05.049 · Cited by 277
Biomedical applications of carbon nanomaterials: Drug and gene delivery potentials
Mohajeri, M., Behnam, B., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.26899 · Cited by 258
Nishanth, R. P., Jyotsna, R. G., Schlager, J. J., Hussain, S. M., & Reddanna, P. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.541604 · Cited by 216
Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles
Arms, L., Smith, D. W., Flynn, J., Palmer, W., Martin, A., Woldu, A., & Hua, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00802 · Cited by 159
Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers
Yan, H., Xue, Z., Xie, J., Dong, Y., Ma, Z., Sun, X., Kebebe Borga, D., Liu, Z., & Li, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s220087 · Cited by 113
Functionalized carbon nanotubes for anticancer drug delivery
Lay, C. L., Liu, J., & Liu, Y. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.11.34 · Cited by 71
Koralli, P., D. Nega, A., Vagiaki, L. E., Pavlou, A., Siskos, M. G., Dimitrakopoulou-Strauss, A., Gregoriou, V. G., & Chochos, C. L. (2020) · Materials Chemistry Frontiers · doi:10.1039/d0qm00195c · Cited by 37
Metadata
- Authors
- Wu, W., Li, R., Bian, X., Zhu, Z., Ding, D., Li, X., Jia, Z., Jiang, X., & Hu, Y.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-08-24
- Volume
- 3
- Issue
- 9
- Pages
- 2740-2750
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2066472222
- Cited by
- 247
- References
- 1
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.